Skip to end of banner
Go to start of banner

Data File

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 8 Next »

column nameconceptexampleGDC equivalentfaceted on GDCGDC referencesizerestricted valuescommentsin AMP-AD portalin NF portaldesired for CSBC/PS-ONGDC equivalent
disease_typeThe text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Acinar Cell Neoplasms
  • Adenomas and Adenocarcinomas
  • Adnexal and Skin Appendage Neoplasms
  • Basal Cell Neoplasms
  • Blood Vessel Tumors
case/disease_typeyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case






siteThe text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Accessory sinuses
  • Adrenal gland
  • Anus and anal canal
  • Base of tongue
  • Bladder
case/primary_siteyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=case






ethnicityAn individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • hispanic or latino
  • not hispanic or latino
  • Unknown
  • not reported
  • not allowed to collect
demographic/ethnicityyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic






genderText designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. [Explanatory Comment 1: Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.]
  • female
  • male
  • unknown
  • unspecified
  • not reported
demographic/genderyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic






raceAn arbitrary classification of a taxonomic group that is a division of a species. It usually arises as a consequence of geographical isolation within a species and is characterized by shared heredity, physical attributes and behavior, and in the case of humans, by common history, nationality, or geographic distribution. The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.
  • white
  • american indian or alaska native
  • black or african american
  • asian
  • native hawaiian or other pacific
demographic/raceyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=demographic






tissue_or_organ_of_originThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/tissue_or_organ_of_originyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






age_at_diagnosisAge at the time of diagnosis expressed in number of days since birth.
diagnosis/age_at_diagnosisyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






days_to_last_follow_upTime interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.
diagnosis/days_to_last_follow_upnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






days_to_last_known_disease_statusTime interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.
diagnosis/days_to_last_known_disease_statusnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






days_to_recurrenceNumber of days between the date used for index and the date the patient's disease recurred.
diagnosis/days_to_recurrencenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






last_known_disease_statusText term that describes the last known state or condition of an individual's neoplasm.
  • Distant met recurrence/progression
  • Loco-regional recurrence/progression
  • Biochemical evidence of disease without structural correlate
  • Tumor free
diagnosis/last_known_disease_statusnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






morphologyThe third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data.
diagnosis/morphologynohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






primary_diagnosisText term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdominal desmoid
  • Abdominal fibromatosis
  • Achromic nevus
  • Acidophil adenocarcinoma
  • Acidophil adenoma
diagnosis/primary_diagnosisnohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






progression_or_recurrenceYes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.
  • yes
  • no
  • unknown
  • not reported
  • Not Allowed To Collect
diagnosis/progression_or_recurrencenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






site_of_resection_or_biopsyThe text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).
  • Abdomen, NOS
  • Abdominal esophagus
  • Accessory sinus, NOS
  • Acoustic nerve
  • Adrenal gland, NOS
diagnosis/site_of_resection_or_biopsynohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






tumor_gradeNumeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.
  • G1
  • G2
  • G3
  • G4
  • GX
diagnosis/tumor_gradenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






tumor_stageThe extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. The accepted values for tumor_stage depend on the tumor site, type, and accepted staging system. These items should accompany the tumor_stage value as associated metadata.
diagnosis/tumor_stagenohttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis






vital_statusThe survival state of the person registered on the protocol.
  • alive
  • dead
  • lost to follow-up
  • unknown
  • not reported
diagnosis/vital_statusyeshttps://docs.gdc.cancer.gov/Data_Dictionary/viewer/#?view=table-definition-view&id=diagnosis
































  • No labels

0 Comments

You are not logged in. Any changes you make will be marked as anonymous. You may want to Log In if you already have an account.